DHARINI SUN: Open Payments
NPI 1558355743 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 16 payments from 11 companies in 2025. Trend: 2023 $94 · 2024 $299 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $71 |
| Novo Nordisk Inc | 2 | $47 |
| PFIZER INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $38 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| UCB, Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: EVENITY, Wegovy, NURTEC ODT, MOUNJARO, STRENSIQ, UNITHROID, Bimzelx, INGREZZA.
Industry payments across CT — which companies pay providers there.
